By understanding the specific roles of CTLA-4 and PD-1 in T cell regulation within the context of SLE, we can develop targeted therapies that selectively modulate immune responses without compromising overall immune defense. The gene discussed is PDCD1; the disease is systemic lupus erythematosus.